// App-Quantinova.ai

: Genomic and Transcriptomic Association Studies Identify 17 Novel Susceptibility Loci for Venous Thromboembolism: The INVENT Consortium

Researchers

Presenter

  • S. Lindstrom

Principal Investigators

  • L. Wang

  • W. Gordon

  • J.-B. Hansen

  • A. van Hylckama Vlieg

  • M. de Andrade

  • B. Psaty

  • W. Tang

  • P. Kraft

  • A. Reiner

  • K. Hveem

  • D. Chasman

  • P. Ridker

  • P.-E. Morange

  • A. Johnson

  • C. Kabrhel

  • D.-A. Tregouet

  • N. Smith

Medical Centers

  • University of Washington, Seattle, WA, United States

  • The Arctic University of Norway, K.G. Jebsen Thrombosis Research and Expertise Center, Department of Clinical Medicine, Tromsø, Norway

  • Leiden University Medical Centre, Leiden, Netherlands

  • Mayo Clinic, Rochester, United States

  • University of Minnesota, Minneapolis, MN, United States

  • Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, United States

  • Norwegian University of Science and Technology, Trondheim, Norway

  • Brigham and Womens Hospital, Boston, MA, United States

  • Brigham and Womens Hospital, Boston, MA, United States

  • Aix Marseille University, Marseille, France

  • National Heart, Lung, and Blood Institute, Framingham, United States

  • Massachusetts General Hospital, Department of Surgery, Boston, United States

  • University Hospital of Bordeaux, Bordeaux, France

Locations

  • United States

  • Norway

  • Netherlands

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved